The US Supreme Court in its Teva Pharmaceuticals USA v Sandoz ruling has outlined a new rule for the Federal Circuit when reviewing the underlying facts in a district court’s claim construction. One observer described it as “a ground shift, but not a true earthquake”
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
National groups for the UK and the Netherlands have flagged concerns with the choice of venue, following a formal complaint from Australia’s national group